International CongressesEuroPCR 2018

EuroPCR 2018

solaci
solaci
604
0

Here you will find the highlights of the EuroPCR 2018, held on May 22-25 in the city of Paris, France.

If you cannot view the articles, click here

Previous article
Is TAVR Durable Beyond 5 Years?
Next article
EuroPCR 2018 | SCAAR Registry at 10 years: FFR improves decision making in the long term
solaci
solaci

More articles by this author

EuroPCR 2024

solaci - 0
Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

solaci - 0
Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

solaci - 0
Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

solaci - 0
Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

EuroPCR 2024

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Dr. Juan Manuel Pérez - 0
Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Dr. Juan Manuel Pérez - 0
Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...